IPOs 2022 (US BIOTECH)

Last Update: Jan 6, 2022

Company Targets, Platforms Indications Lead Phase
Vigil Neuroscience, Inc.Anti-TREM2 mAb, small molecule TREM2 agonistNeurology, ALSP, cALD, Alzheimer'sI
CinCor Pharma, Inc.Aldosterone synthase inhibitorUncontrolled Hypertension and high plasma aldosteroneII
Amylyx Pharmaceuticals, Inc.Sodium phenylbutyrate/taurursodiolALS, Alzheimer's, Wolfram syndromeNDA/MAA
Company Targets, Platforms Indications
Vigil Neuroscience, Inc.Anti-TREM2 mAb, small molecule TREM2 agonistNeurology, ALSP, cALD, Alzheimer's
CinCor Pharma, Inc.Aldosterone synthase inhibitorUncontrolled Hypertension and high plasma aldosterone
Amylyx Pharmaceuticals, Inc.Sodium phenylbutyrate/taurursodiolALS, Alzheimer's, Wolfram syndrome

Have feedback? Tweet or DM me @blackseedbio on Twitter, or contact me here.

If you want to get notified when updates are available, please consider subscribing.

SUBSCRIBE